Pharming « Terug naar discussie overzicht

Gestys Health Biotech heeft 4,7 % in Pharming sinds 31-01-2014

13 Posts
[verwijderd]
1
www.tradingsat.com/pharming-group-NL0...

engelse vertaling via bing translator:

(Tradingsat.com) - Pharming Group, listed on Euronext Amsterdam (mnemonic code PHARM), biotechnology company continued Monday its spectacular flight. After a leap of 11.5% Friday, as flames of more than 20% (+ 24.6% in 0.628 euros at mid-day) to new more highs from April 2012.

The increase in the volume of trade is confirmed. After 144.7 million shares traded Friday (or 40.4% of the share capital of the company), volumes already reach 123.2 million shares today at 12 noon, testifying to the strong interest in the title, whose market capitalization has multiplied by more than 4 since the beginning of the year (+ 330%).

Indeed, the title is not unknown to some managers. It's part for several months of the portfolio of the Fund Gestys Health Biotech (of the management Gestys company), which he represented 4.70% of outstanding at January 31, 2014.

Alleen snap ik niet dat dit niet in de AFM-registers staat. Of ligt de meldingsplicht boven de 5 % ??

In ieder geval is er weer een grote farmaceutische jongen ingestapt !!!!
[verwijderd]
0
quote:

chris63 schreef op 17 februari 2014 13:10:

www.tradingsat.com/pharming-group-NL0...

engelse vertaling via bing translator:

(Tradingsat.com) - Pharming Group, listed on Euronext Amsterdam (mnemonic code PHARM), biotechnology company continued Monday its spectacular flight. After a leap of 11.5% Friday, as flames of more than 20% (+ 24.6% in 0.628 euros at mid-day) to new more highs from April 2012.

The increase in the volume of trade is confirmed. After 144.7 million shares traded Friday (or 40.4% of the share capital of the company), volumes already reach 123.2 million shares today at 12 noon, testifying to the strong interest in the title, whose market capitalization has multiplied by more than 4 since the beginning of the year (+ 330%).

Indeed, the title is not unknown to some managers. It's part for several months of the portfolio of the Fund Gestys Health Biotech (of the management Gestys company), which he represented 4.70% of outstanding at January 31, 2014.

Alleen snap ik niet dat dit niet in de AFM-registers staat. Of ligt de meldingsplicht boven de 5 % ??

In ieder geval is er weer een grote farmaceutische jongen ingestapt !!!!
Vertrouwen is building... Gogogo...
[verwijderd]
1
Dan weten we dus niet hoeveel andere grote farmaceutische bedrijven al zijn ingestapt ??
Kan wel een groot deel van de volumes verklaren !!
[verwijderd]
0
VolvoR
0
13 Posts
Aantal posts per pagina:  20 50 100 | Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met uw e-mailadres en wachtwoord.

Direct naar Forum

Detail

Vertraagd 25 apr 2024 11:48
Koers 0,897
Verschil -0,008 (-0,88%)
Hoog 0,910
Laag 0,889
Volume 1.023.019
Volume gemiddeld 6.865.849
Volume gisteren 6.519.524

EU stocks, real time, by Cboe Europe Ltd.; Other, Euronext & US stocks by NYSE & Cboe BZX Exchange, 15 min. delayed
#/^ Index indications calculated real time, zie disclaimer, streaming powered by: Infront